title: [Recombinant interferon alfa in the treatment of essential thrombocythemia].
abstract: Essential thrombocythaemia, a clonal myeloproliferative disease characterized by a persisting increase of the number of thrombocytes, their abnormal morphology and function, is a special clinical and therapeutic problem which calls for a comprehensive approach. Based on a group of their own patients and on data from the literature, the authors discuss the asset of interferon alpha in the treatment of essential thrombocythaemia.
authors.affiliation: Oddelenie klinickej hematológie FNsP, Kosice.
authors.forename: E
authors.initials: E
authors.lastname: Tóthová
authors.forename: M
authors.initials: M
authors.lastname: Fricová
authors.forename: B
authors.initials: B
authors.lastname: Mudronová
authors.forename: N
authors.initials: N
authors.lastname: Stecová
authors.forename: E
authors.initials: E
authors.lastname: Svorcová
authors.forename: A
authors.initials: A
authors.lastname: Kafková
authors.forename: T
authors.initials: T
authors.lastname: Guman
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D013922:Thrombocytosis / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins